Published in J Hepatol on May 01, 2000
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet (1999) 2.68
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest (2001) 2.49
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology (2001) 1.68
Heterogeneity of hemochromatosis in Italy. Gastroenterology (1998) 1.38
Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology (1992) 1.27
Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood (1997) 1.17
Iron regulatory proteins in pathobiology. Biochem J (2000) 1.12
Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J Membr Biol (2005) 1.05
Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood (2000) 1.03
C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration. J Biol Chem (1996) 1.03
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion. Br J Dermatol (1986) 1.02
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol (2001) 0.99
HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98
Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Med (1986) 0.94
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology (1994) 0.94
Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis. Am J Pathol (1998) 0.88
The role of Ito cells in the biosynthesis of HGF-SF in the liver. EXS (1993) 0.87
Expression of messenger RNA for liver functions following 70% and 90% hepatectomy. J Hepatol (1996) 0.86
Lack of coordinate control of ferritin and transferrin receptor expression during rat liver regeneration. Hepatology (1998) 0.85
Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types. Arzneimittelforschung (1989) 0.84
Coproporphyrin excretion in healthy newborn babies. J Pediatr Gastroenterol Nutr (1984) 0.84
Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils. The effect of silybin. J Bioenerg Biomembr (2000) 0.82
Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation. Eur J Biochem (1995) 0.82
Transferrin receptor gene expression during rat liver regeneration. Evidence for post-transcriptional regulation by iron regulatory factorB, a second iron-responsive element-binding protein. J Biol Chem (1994) 0.81
Translational regulation of ferritin synthesis in rat liver. Effects of chronic dietary iron overload. Biochem J (1989) 0.81
Hereditary hemochromatosis masquerading as rheumatoid arthritis. Ann Ital Med Int (2001) 0.79
Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. J Hepatol (1995) 0.77
G80S-linked ferroportin disease: the first clinical description in a Greek family. Blood Cells Mol Dis (2008) 0.76
3-Hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo. Bioorg Med Chem (2001) 0.76
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents. Hepatology (1998) 0.76
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? JPEN J Parenter Enteral Nutr (1985) 0.75
Hepatitis B virus infection in porphyria cutanea tarda. Liver (1986) 0.75
Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein. Mol Cell Biol (1995) 0.75
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. Pharmacology (2001) 0.75
[Hereditary coproporphyria. A familial study]. Recenti Prog Med (1984) 0.75
Porphyria cutanea tarda in beta-thalassemia trait carriers. Dermatologica (1984) 0.75
[Internal medicine evaluation of the surgical risk in cirrhosis patients]. Minerva Med (1987) 0.75
Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion. Liver (1984) 0.75
[Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis]. Minerva Med (1984) 0.75
[Diagnosis of digestive diseases]. G Clin Med (1990) 0.75